190 filings
Page 5 of 10
8-K
ptl8x4
19 Feb 21
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation
9:17am
8-K
njwc47r rgm
16 Feb 21
Regulation FD Disclosure
9:00am
8-K
dgpe6i672 bie8
5 Jan 21
Termination of a Material Definitive Agreement
8:30am
8-K
j9s77g03w2m8l 1w6
16 Dec 20
Evolus Provides Update on United States International Trade Commission (ITC) Case
5:07pm
8-K
de10c5j4xsxs
19 Nov 20
Regulation FD Disclosure
5:03pm
8-K
kuegcewdpvidn3fbh2m
29 Oct 20
Evolus Reports Third Quarter 2020 Results and Provides Business Update
4:22pm
8-K
u7wpv2o
22 Oct 20
Regulation FD Disclosure
4:28pm
8-K
6r1apttmn4v3yt3
10 Aug 20
Evolus Reports Second Quarter 2020 Results and Provides Business Update
4:06pm
D
fnvet7wz7
16 Jul 20
$40M in Convertible Promissory Note, sold $40M, 1 investor
9:31pm
8-K
7udwx3ly ssgyeok
7 Jul 20
Evolus Provides Update on International Trade Commission (ITC) Case
9:24am
8-K
66wbd
2 Jun 20
Regulation FD Disclosure
9:00am
8-K
tefs8l au
11 May 20
Evolus Reports First Quarter 2020 Results and Provides Business Update
4:01pm
8-K
j1ilp
4 May 20
Submission of Matters to a Vote of Security Holders
4:22pm
DEFA14A
7hsr22dhcm2yrg3u4c8
21 Apr 20
Additional proxy soliciting materials
4:13pm
8-K
6jmmcfrnllkwude 0wt
16 Apr 20
Evolus Provides Strategic Business Update
4:53pm
DEFA14A
8e9kr3ko
17 Mar 20
Additional proxy soliciting materials
4:48pm